PAG
BLCM

Private Advisor Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Private Advisor Group’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,380
Closed -$10K – 3681
2020
Q2 		$10K Buy
+1,380
New +$9.39K ﹤0.01% 2951

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Private Advisor Group's BLCM Position: Q3 2020 in Review

Private Advisor Group sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2020, closing a stake of 1,380 shares — an estimated $10K sold.

Private Advisor Group first reported a position in BLCM in Q2 2020 and held it in 1 quarter. The position peaked at $10K in Q2 2020. 22 funds tracked by Wall St. Rank hold BLCM as of Q3 2020.

  • Private Advisor Group reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 1,380 Bellicum Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10K.
  • Private Advisor Group first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Bellicum Pharmaceuticals, Inc. position peaked at $10K in Q2 2020.
  • 22 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.